VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PRQR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PRQRProQR Therapeutics N.V.
$1.15$116M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPRQRRevenue History

PRQR logoProQR Therapeutics N.V. (PRQR) Revenue History

Annual and quarterly revenue from 2013 to present

TTM Revenue$18.6M▲ +$3.3M vs FY2025
YoY Growth+133.3%Excellent
Q2 2026$8.9M+133.3% YoY · +330.9% QoQ
Revenue CAGR
3Y+62.0%
→
5Y+71.5%
→
10Y+5.0%
Growth decelerating ↓
Best Fiscal Year$18.9M (2024)
Best Quarter$9.4M (Q4 2015)
Revenue per Share$0.18
Revenue per Employee$112K

PRQR Revenue Over Time (2013–2025)

PRQR Revenue Growth History

6 of 11 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
2013—
2014—
2015+2905.4%
2016-75.7%
2017-167.0%
2018+423.2%
2019-60.9%
2020-46.8%
2021+29.7%
2022+169.2%
2023+81.2%
2024+190.2%
2025-19.2%
FY2013 revenue growth
N/A
FY2014 revenue growth
N/A
FY2015 revenue growth
+2905.4%
FY2016 revenue growth
-75.7%
FY2017 revenue growth
-167.0%
FY2018 revenue growth
+423.2%
FY2019 revenue growth
-60.9%
FY2020 revenue growth
-46.8%
FY2021 revenue growth
+29.7%
FY2022 revenue growth
+169.2%
FY2023 revenue growth
+81.2%
FY2024 revenue growth
+190.2%
FY2025 revenue growth
-19.2%
DeclineStrong growth
↓ 1-year revenue declineBest: +2905.4% (FY2015)Worst: -167.0% (FY2017)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q2 2026$8.9M+133.3%
Q1 2026$2.1M-54.3%
Q4 2025$4.7M+8.8%
Q3 2025$2.9M-24.1%
Q2 2025$3.8M-39.5%
Q1 2025$4.5M+1.6%
Q4 2024$4.3M+31.2%
Q3 2024$3.8M+180.5%
Seasonal Revenue Pattern (fiscal quarters)
Q1
11%
Q2
16%
Q3
16%
Q4
56%

Multi-year avg. share of annual revenue by fiscal quarter

Revenue Breakdown (FY 2024)

PRQR's revenue distribution by segment and geography for fiscal year 2024

By Product/Segment

Up-front payments75.4%
Milestone payments24.6%

PRQR Revenue Analysis (2013–2025)

Current Revenue & Growth

As of November 18, 2026, ProQR Therapeutics N.V. (PRQR) generated trailing twelve-month (TTM) revenue of $18.6 million, reflecting explosive growth of +133.3% year-over-year. The most recent quarter (Q2 2026) recorded $8.9 million in revenue, up 330.9% sequentially.

Historical Growth Trajectory

PRQR's 5-year compound annual growth rate (CAGR) stands at +71.5%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +62.0% is below the 5-year average, signalling a growth deceleration in recent years. ProQR Therapeutics N.V.'s highest annual revenue of $18.9 million was recorded in 2024.

Revenue by Segment

PRQR's revenue is primarily driven by Up-front payments (75%), and Milestone payments (25%). With over half of revenue concentrated in Up-front payments, the company has a focused business model while developing other growth vectors.

Peer Comparison

Compared to Healthcare sector peers — including EDIT (+7.4% YoY), NTLA (-8.1% YoY), and CRSP (-33.1% YoY) — PRQR has outperformed the peer group in revenue growth. Compare PRQR vs EDIT →

PRQR Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
PRQR logoPRQRCurrent$19M+133.3%+71.5%-275.9%
EDIT logoEDIT$41M+7.4%-14.9%-245.2%
NTLA logoNTLA$68M-8.1%+3.1%-651.7%
CRSP logoCRSP$4M-33.1%+37.3%-16191.4%
BEAM logoBEAM$140M+163.3%+466.3%-274.6%
ARWR logoARWR$451M-45.6%+26.7%-156.9%
Best in groupLowest in group

PRQR Historical Revenue Data (2013–2025)

1–13 of 13 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$15.3M-19.2%$12.7M83.0%$-42,154,897-275.9%
2024$18.9M+190.2%$18.9M100.0%$-30,472,000-161.2%
2023$6.5M+81.2%$6.5M100.0%$-31,859,000-489.1%
2022$3.6M+169.2%$3.6M100.0%$-65,159,000-1813.0%
2021$1.3M+29.7%$1.3M100.0%$-57,210,000-4285.4%
2020$1.0M-46.8%$1.0M100.0%$-42,368,000-4117.4%
2019$1.9M-60.9%$-114,890,000-5943.6%$-57,445,000-2971.8%
2018$4.9M+423.2%$4.0M80.1%$-36,293,000-734.5%
2017$-1,529,000-167.0%$-2,530,314165.5%$-40,498,0002648.7%
2016$2.3M-75.7%$1.0M43.8%$-39,573,000-1734.1%
2015$9.4M+2905.4%$8.9M94.9%$-27,003,000-287.1%
2014$313K-$313K100.0%$-16,461,000-5259.1%
2013$0-$0-$-3,239,000-
Consensus & Technical Research Suite
Open PRQR Terminal

PRQR Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

13+ years return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PRQR — Frequently Asked Questions

Quick answers to the most common questions about buying PRQR stock.

Is PRQR's revenue growth accelerating or slowing?

PRQR revenue growth is accelerating. TTM revenue reached $19M, up +133.3% year-over-year — ahead of the 5-year CAGR of +71.5%. This indicates the business is expanding faster than its historical baseline.

What is PRQR's revenue history from 2013 to 2026?

ProQR Therapeutics N.V. (PRQR) revenue history spans 2013 to 2026. TTM revenue as of 2026 is $19M, growing at +133.3% YoY. The 5-year CAGR is +71.5%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is PRQR's long-term revenue growth rate (CAGR)?

ProQR Therapeutics N.V.'s 5-year revenue CAGR of +71.5% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +133.3% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for PRQR.

Why does PRQR's quarterly revenue fluctuate?

PRQR quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. ProQR Therapeutics N.V.'s revenue data from 2013 to 2026 shows full historical quarterly detail on this page.

How is PRQR's revenue distributed by segment?

PRQR reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does PRQR's revenue compare to industry peers?

ProQR Therapeutics N.V. (PRQR) with TTM revenue of $19M and +133.3% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.